^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ACT-1004-1239

    i
    Other names: ACT-1004-1239
    Associations
    News
    Trials
    Company:
    Idorsia
    Drug class:
    CXCR7 inhibitor
    Associations
    News
    Trials